DC Chemicals Limited

DC Chemicals Limited is a world-leading supplier of drug active molecules, committed to providing global drug research and development, as well as medical research clients, with a wide range of innovative and comprehensive high-quality small molecule active compounds. Established in 2013, DC Chemicals offers over 10,000 specific inhibitors, agonists, and cationic liposomes that act on gene delivery, gene editing, RNA vaccines, epigenetics, PI3K/Akt/mTOR, apoptosis, MAPK, Wnt, and other 20 signaling pathways with more than 1,000 target proteins. These cover popular disease research areas such as cancer, neuroscience, and immunology.

DC Chemicals has many globally exclusive compounds and a professional team tracking new pharmaceutical and life science research progress. This allows DC Chemicals to provide the latest research small molecule compounds to meet diverse research needs. As one of the earliest companies in the world to develop and research cationic liposomes, DC Chemicals provides a large number of liposomes for global RNA and gene editing companies for LNP research and screening. DC Chemicals currently boasts one of the largest cationic/ionizable liposome libraries in the world.

Located in boston, US, DC Chemicals' small molecule compounds are offered at competitive prices, and under strict quality control, maintain a quality standard equal to or better than similar reagent companies. DC Chemicals continues to expand its offerings and improve its services to better serve the biotechnology research community. We invite the manager of DC Chemicals Limited to create a customized and exclusive company showcase and product listing on our platform to further highlight their innovative solutions.